Covid-19

CV. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review

Chi, J., Gong, W. & Gao, Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet 303, 337–345 (2021). https://doi.org/10.1007/s00404-020-05889-5 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 25/07/2021 Abstract This systematic review summarizes the clinical features and

CV. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review Leer más »

CV. Mixing vaccines may boost immune responses

Gretchen Vogel. Science  11 Jun 2021: DOI: 10.1126/science.372.6547.1138 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 23/07/2021 From combination studies support measures to stretch supplies, avoid side effects Science’s COVID-19 reporting is supported by the Heising-Simons Foundation Faced with short supplies of COVID-19 vaccines and unforeseen side effects,

CV. Mixing vaccines may boost immune responses Leer más »

CV. Actualización Epidemiológica Enfermedad por Coronavirus (COVID-19) 22 de julio de 2021

Organización Panamericana de la Salud / Organización Mundial de la Salud. Actualización epidemiológica: Enfermedad por Coronavirus (COVID-19). 22 de julio de 2021, Washington, D.C.: OPS/OMS; 202 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 23/07/2021 Resumen ejecutivo• Hasta el 21 de julio 2021, fueron notificados 191.281.182 casos

CV. Actualización Epidemiológica Enfermedad por Coronavirus (COVID-19) 22 de julio de 2021 Leer más »

CV. “Neurological manifestations of COVID-19” – guideline of the German society of neurology

Berlit et al. Neurological Research and Practice (2020) 2:51 https://doi.org/10.1186/s42466-020-00097-7 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 23/07/2021 AbstractInfection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a previously unknown clinical picture, which is known as COVID-19 (COrona VIrus Disease-2019) and was

CV. “Neurological manifestations of COVID-19” – guideline of the German society of neurology Leer más »

CV. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study

Susan D Hillis,  et al. DOI:https://doi.org/10.1016/S0140-6736(21)01253-8 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 23/07/2021 Summary The COVID-19 pandemic priorities have focused on prevention, detection, and response. Beyond morbidity and mortality, pandemics carry secondary impacts, such as children orphaned or bereft of their caregivers. Such children often face

CV. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study Leer más »

CV. Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study

Felten R, Kawka L, Dubois M, et al. Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study. Lancet Rheumatol 2021; published online July 21. https://doi.org/10.1016/S2665-9913(21)00221-6 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 23/07/2021 131 vaccine candidates have been evaluated for SARS-CoV-2

CV. Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study Leer más »

CV. COVID-19. Exitus letalis materno ¿Tragedia evitable?

29° Teleclínica ECHO “Embarazo de alto riesgo” Coordinadora Dra. Judith Toro Merlo Especialista en Obstetricia y Ginecología Coordinador invitado Dr. Carlos Cabrera Lozada Especialista en Obstetricia y Ginecología Especialistas invitados Presentación de caso Dra. Dariela Toro Carrero Residente del Servicio de Obstetricia y Ginecología Hospital «Dr. Pablo Acosta Ortiz» San Fernando de Apure – Estado

CV. COVID-19. Exitus letalis materno ¿Tragedia evitable? Leer más »

CV. Efectividad de las vacunas contra el Covid-19 contra la variante B.1.617.2 (Delta)

Jamie López Bernal  et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Inglés J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 22/07/2021 Resumen Antecedentes: La variante B.1.617.2 (delta) del coronavirus 2 del síndrome respiratorio agudo severo (SARS-CoV-2), el

CV. Efectividad de las vacunas contra el Covid-19 contra la variante B.1.617.2 (Delta) Leer más »